Aortic Valve Insufficiency Clinical Trial
Official title:
Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect
The major risk factors of aortic valve replacement in three outlet types VSD after surgical repair were the severity of preoperative AR and older operation age. For those patients with less than moderate degree AR preoperatively, AR progressed rarely and all in those with aortic valvar and subvalvar anomalies.
Progression of aortic regurgitation (AR) in repaired outlet (juxta-arterial, muscular outlet
and perimembranous outlet) ventricular septal defect (VSD) remains unclear.
From 1987 to 2002, 411 patients with complete follow-up after repair of outlet VSD
constituted the study population. Study end point was aortic valve replacement or mortality.
Aortic valve replacement was performed in seventeen patients (4.1%), in whom logistic
regression showed only the severity of preoperative AR and age at VSD repair as the
predictors. After excluding the eleven patients with endocarditis from analysis, there were
377 patients with none to mild AR (Group I) and 23 with moderate to severe AR (Group II)
preoperatively. Total follow-up was 2,230 person-years. After VSD repair, the 5- and 10-year
freedom from aortic valve replacement in Group I was 100%, and in Group II 50.2%. In Group
II, ten patients received aortic valve replacement and 8 underwent valvuloplasty with VSD
repair. One patient needed valve replacement four years later. Age at VSD repair was the
predictor for aortic valve replacement. In Group I, AR progressed in four patients (1.2%,
two juxta-arterial and two perimembranous outlet) 3.5 to 7.9 years later and was associated
with aortic valvar or subvalvar anomalies. The event-free curves in three outlet types VSD
showed no differences.
Although AR progressed rarely (probably not in muscular outlet type) in repaired outlet
types VSD with none to mild preoperative AR, in the presence of aortic valvar or subvalvar
anomalies, early surgical repair of the VSD is still warranted.
;
Observational Model: Case Control, Time Perspective: Longitudinal
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04149600 -
Identification of Genetic Causes of Calcific Aortic Valve Disease
|
||
Enrolling by invitation |
NCT04035356 -
HAART Annuloplasty Device Valve Repair Registry
|
||
Unknown status |
NCT01201070 -
Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery
|
Phase 4 | |
Active, not recruiting |
NCT04281771 -
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
|
N/A | |
Completed |
NCT03644784 -
Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.
|
||
Recruiting |
NCT02288871 -
Pilot Trial: Comparison of Flow Patterns
|
N/A | |
Completed |
NCT01651780 -
Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
|
Phase 3 | |
Completed |
NCT01171625 -
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
|
N/A | |
Terminated |
NCT00598598 -
Echocardiographic Assessment of Cardiovascular Changes in Long Term Space Flight
|
N/A | |
Recruiting |
NCT05295628 -
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
|
N/A | |
Recruiting |
NCT06034028 -
J-Valve TF Early Feasibility Study
|
N/A | |
Recruiting |
NCT06295068 -
Evaluation of ARi With OpSens SavvyWire
|
||
Completed |
NCT05742789 -
Effect of Anesthetics on Troponin I and С-reactive Protein
|
Phase 1 | |
Recruiting |
NCT05172973 -
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
|
N/A | |
Completed |
NCT00727181 -
An Observational, Prospective Evaluation of the Trifecta™ Valve
|
N/A | |
Active, not recruiting |
NCT04415047 -
The JenaValve ALIGN-AR Pivotal Trial
|
N/A | |
Not yet recruiting |
NCT02623907 -
China Valve Registry Study-1
|
N/A | |
Completed |
NCT00475267 -
Aortic Valve Replacement With Trifecta(TM)
|
N/A | |
Completed |
NCT00478803 -
Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root. CAVIAAR
|
Phase 3 | |
Completed |
NCT00001314 -
Investigation of Heart Function in Patients With Heart Valve Defects
|
N/A |